Quest 10 Wealth Builders, Inc. Gilead Sciences, Inc. Transaction History
Quest 10 Wealth Builders, Inc.
- $108 Billion
- Q3 2025
A detailed history of Quest 10 Wealth Builders, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Quest 10 Wealth Builders, Inc. holds 134 shares of GILD stock, worth $16,752. This represents 0.01% of its overall portfolio holdings.
Number of Shares
134
Previous 117
14.53%
Holding current value
$16,752
Previous $13 Million
14.68%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding GILD
# of Institutions
2,378Shares Held
1.01BCall Options Held
10.4MPut Options Held
8.12M-
Black Rock Inc. New York, NY121MShares$15.1 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.9 Billion0.21% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.39 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.65 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.77 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $157B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...